China VC Weekly: Biotech, Autonomous Driving and AI
(Source: Pony.ai)
Gracell Biotechnologies raises $100 million in Series C round
Gracell Biotechnologies Inc., a Chinese clinical-stage biopharmaceutical company dedicated to developing efficacious and affordable cell therapies for the treatment of cancer, announced it has raised $100 million in its Series C funding round. The round was led by Wellington M…
Keep reading with a 7-day free trial
Subscribe to Pandaily to keep reading this post and get 7 days of free access to the full post archives.